
| Code | Product | Strength | Indication | GMP | Registration |
|---|---|---|---|---|---|
| UB960 | Ibuprofen Sustained-Release Capsules | 0.3g | Reduction of symptoms of osteoarthritis, rheumatoid arthritis, low back pain, and fever; Primary dysmenorrhoea; Acute pain; Migraine; Headache and fever caused by common cold | CN - NMPA | China |
| UB956 | Flurbiprofen Cataplasms | 12g:40mg (13.6cm*10cm) | Osteoarthritis; Rheumatoid arthritis; Lumbago; Periarthritis; Tenosynovitis | CN - NMPA | China |
| UB944 | Paracetamol Tablet | 0.5g | Pain; Pyrexia | CN - NMPA | China |
| UB938 | Compound Aminopyrine Phenacetin Tablet | 0.15g:0.15g | Pyrexia; Pain | CN - NMPA | China |
| UB937 | Ibuprofen Tablet | 0.1g | Pain; Pyrexia; Rheumatoid arthritis | CN - NMPA | China |
| UB922 | Elagolix Sodium Tablet | 150mg, 200mg | Endometriosis associated pain | CN - NMPA | China |
| UB901 | Gabapentin Capsules | 100mg;300mg;400mg;600mg | Postherpetic neuralgia; Partial onset seizures | CN - NMPA | China |
| UB900 | Duloxetine Hydrochloride Enteric Capsules | 30mg | Major depressive disorder; Generalized anxiety disorder; Diabetic peripheral neuropathic pain | CN - NMPA | China |
| UB899 | Duloxetine Hydrochloride Enteric-coated Tablets | 20mg;30mg;60mg | Major depressive disorder; Generalized anxiety disorder; Diabetic peripheral neuropathic pain; Fibromyalgia; Chronic musculoskeletal pain | CN - NMPA | China |
| UB890 | Naproxen Sustained Release Capsules | 250mg | Rheumatoid arthritis; Osteoarthritis; Ankylosing spondylitis; Acute gout; Pain; Primary dysmenorrhoea | CN - NMPA | China |
| UB889 | Ropivacaine Mesylate Injection | 10ml:89.4mg | Local anesthesia; Regional anesthesia; Surgical anesthesia; Acute pain management; Epidural block; Major nerve block; Local infiltration anesthesia | CN - NMPA | China |
| UB888 | Penehyclidine Hydrochloride Injection | 1ml:0.5mg; 1ml:1mg; 2ml:2mg | Preanesthetic medication; Salivary hypersecretion; Airway secretion; Organophosphate poisoning | CN - NMPA | China |
| UB887 | Propofol Injection | 20ml:0.2g | General anaesthesia induction; General anaesthesia maintenance; Intensive care unit sedation; Sedation for diagnostic procedure; Sedation for surgical procedure | CN - NMPA | China |
| UB886 | Naloxone Hcl Injection | 1ml:0.4mg | Opioid-induced depression; Respiratory depression; Acute opioid overdose | CN - NMPA | China |
| UB885 | Mivacurium Chloride Injection | 10ml:20mg;5ml:10mg | Tracheal intubation; Skeletal muscle relaxation | CN - NMPA | China |
| UB884 | Flumazenil Injection | 2ml:0.2mg; 5ml:0.5mg; 10ml:1.0g | Reversal of benzodiazepine sedative effects; Benzodiazepine overdose | CN - NMPA | China |
| UB883 | Etomidate Fat Emulsion Injection | 10ml:20mg | Anesthetic general; Surgical procedure | CN - NMPA | China |
| UB882 | Dexmedetomidine Hydrochloride Injection | 1ml:0.1mg; 2ml:0.2mg | Sedation of intubated and mechanically ventilated patients; Sedation of non-intubated patients prior to and/or during surgical procedures | CN - NMPA | China |
| UB880 | Tapentadol Extended Release Tablets | 50mg; 100mg; 150mg | Severe pain; Chronic pain; Neuropathic pain; Diabetic peripheral neuropathy | EU - EMA; US - FDA | Germany |
| UB877 | Fentanyl Citrate Injection | 0.1mg/2ml; 0.5mg/10ml | Postoperative pain; Anesthetic supplement; Analgesia | EU - EMA; US - FDA | Germany; Netherlands; Poland; Italy |
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →